Published in Antimicrob Agents Chemother on October 01, 1989
Neurotoxic effects associated with antibiotic use: management considerations. Br J Clin Pharmacol (2011) 1.57
Effects of novel 6-desfluoroquinolones and classic quinolones on pentylenetetrazole-induced seizures in mice. Antimicrob Agents Chemother (1999) 1.18
Pharmacokinetic-pharmacodynamic contributions to the convulsant activity of fluoroquinolones in rats. Antimicrob Agents Chemother (1999) 0.99
Determination of the excitatory potencies of fluoroquinolones in the central nervous system by an in vitro model. Antimicrob Agents Chemother (1998) 0.97
Involvement of inhibitory and excitatory neurotransmitters in levofloxacin- and ciprofloxacin-induced convulsions in mice. Antimicrob Agents Chemother (1993) 0.92
A new approach for early assessment of the epileptogenic potential of quinolones. Antimicrob Agents Chemother (1998) 0.89
Effects of some excitatory amino acid antagonists and drugs enhancing gamma-aminobutyric acid neurotransmission on pefloxacin-induced seizures in DBA/2 mice. Antimicrob Agents Chemother (1997) 0.87
Quinolones potentiate cefazolin-induced seizures in DBA/2 mice. Antimicrob Agents Chemother (1993) 0.83
Possible intermolecular interaction between quinolones and biphenylacetic acid inhibits gamma-aminobutyric acid receptor sites. Antimicrob Agents Chemother (1994) 0.82
Convulsant and subconvulsant doses of norfloxacin in the presence and absence of biphenylacetic acid alter extracellular hippocampal glutamate but not gamma-aminobutyric acid levels in conscious rats. Antimicrob Agents Chemother (2002) 0.81
Retinal safety of a new fluoroquinolone, pradofloxacin, in cats: assessment with electroretinography. Doc Ophthalmol (2007) 0.80
Pharmacokinetic-pharmacodynamic modelling of the convulsant interaction between norfloxacin and biphenyl acetic acid in rats. Br J Pharmacol (2000) 0.80
Low neurotoxicity of LJC 10,627, a novel 1 beta-methyl carbapenem antibiotic: inhibition of gamma-aminobutyric acidA, benzodiazepine, and glycine receptor binding in relation to lack of central nervous system toxicity in rats. Antimicrob Agents Chemother (1993) 0.77
Association between oral fluoroquinolones and seizures: A self-controlled case series study. Neurology (2016) 0.77
Neurotoxicodynamics of the interaction between ciprofloxacin and foscarnet in mice. Antimicrob Agents Chemother (1998) 0.75
Do we need an intravenous fluoroquinolone? West J Med (1992) 0.75
Moxifloxacin Induced Seizures -A Case Report. Iran J Public Health (2014) 0.75
Accidental overdose of intravenous ofloxacin with benign outcome. Antimicrob Agents Chemother (1991) 0.75
The Effect of Ciprofloxacin Injection on Genetically Absence Prone (Wag/Rij) Rat's Electroencephalogram Characteristics. Basic Clin Neurosci (2013) 0.75
Norfloxacin-induced electroencephalogram alteration and seizures in rats are not triggered by enhanced levels of intracerebral glutamate. Antimicrob Agents Chemother (2003) 0.75
Quinolone antibiotics and suicidal behavior: analysis of the World Health Organization's adverse drug reactions database and discussion of potential mechanisms. Psychopharmacology (Berl) (2016) 0.75
In vitro antibacterial activity of AM-715, a new nalidixic acid analog. Antimicrob Agents Chemother (1980) 26.28
In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents. Antimicrob Agents Chemother (1983) 21.48
In vitro and in vivo activity of DL-8280, a new oxazine derivative. Antimicrob Agents Chemother (1982) 21.31
In vitro and in vivo antibacterial activity of AT-2266. Antimicrob Agents Chemother (1983) 3.80
3H-baclofen and 3H-GABA bind to bicuculline-insensitive GABA B sites in rat brain. Nature (1981) 3.55
Ofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs (1987) 2.95
Gamma-aminobutyric acid binding to receptor sites in the rat central nervous system. Proc Natl Acad Sci U S A (1974) 2.29
Inhibitory effects of quinolone antibacterial agents on gamma-aminobutyric acid binding to receptor sites in rat brain membranes. Antimicrob Agents Chemother (1988) 1.83
GABA-benzodiazepine-barbiturate receptor interactions. J Neurochem (1981) 1.75
Ciprofloxacin: an overview of adverse experiences. J Antimicrob Chemother (1986) 1.62
Adverse effects of the fluoroquinolones. Rev Infect Dis (1988) 1.58
Quinolones, theophylline, and diclofenac interactions with the gamma-aminobutyric acid receptor. Antimicrob Agents Chemother (1988) 1.55
Influences ions, enzymes, and detergents on gamma-aminobutyric acid-receptor binding in synaptic membranes of rat brain. Mol Pharmacol (1977) 1.35
Ciprofloxacin: an update on clinical experience. Am J Med (1987) 1.29
Overview of drug interactions with the quinolones. J Antimicrob Chemother (1988) 1.18
Norfloxacin and seizures. Ann Intern Med (1988) 1.05
Effects of GABA analogues of restricted conformation on GABA transport in astrocytes and brain cortex slices and on GABA receptor binding. J Neurochem (1979) 1.05
Convulsions related to enoxacin. Lancet (1985) 1.04
Comparative stereostructure-activity studies on GABAA and GABAB receptor sites and GABA uptake using rat brain membrane preparations. J Neurochem (1986) 1.01
Neurological toxicity related to pefloxacin. J Antimicrob Chemother (1988) 0.88
Conformational analysis of muscimol, a GABA agonist. J Theor Biol (1979) 0.87
Grand mal epileptic seizures during ciprofloxacin therapy. JAMA (1989) 0.81
In vitro and in vivo activity of DL-8280, a new oxazine derivative. Antimicrob Agents Chemother (1982) 21.31
Mutants of Escherichia coli permeable to actinomycin. Proc Natl Acad Sci U S A (1967) 8.34
Inhibition of development of Kaposi's sarcoma-related lesions by a bacterial cell wall complex. Science (1992) 6.35
Targeted disruption of the Rad51 gene leads to lethality in embryonic mice. Proc Natl Acad Sci U S A (1996) 6.04
MutT protein specifically hydrolyses a potent mutagenic substrate for DNA synthesis. Nature (1992) 5.54
Identification of the major Abeta1-42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition. Nat Med (2000) 4.99
Antimicrobial activity of DU-6859, a new potent fluoroquinolone, against clinical isolates. Antimicrob Agents Chemother (1992) 4.43
Regulation and expression of the adaptive response to alkylating agents. Annu Rev Biochem (1988) 4.32
In vivo comparison of avirulent Vwa- and Pgm- or Pstr phenotypes of yersiniae. Infect Immun (1984) 4.16
In vitro activity of DR-3355, an optically active ofloxacin. Antimicrob Agents Chemother (1988) 4.03
Studies on the physiological defect in rII mutants of bacteriophage T4. J Mol Biol (1966) 3.00
Studies on the pathogenicity of Yersinia enterocolitica. I. Experimental infection in rabbits. Microbiol Immunol (1977) 2.99
Studies on the pathogenicity of Yersinia enterocolitica. II. Interaction with cultured cells in vitro. Microbiol Immunol (1977) 2.96
Isolation and characterization of the active cDNA of the human cell cycle gene (RCC1) involved in the regulation of onset of chromosome condensation. Genes Dev (1987) 2.86
T4 endonuclease involved in repair of DNA. Proc Natl Acad Sci U S A (1970) 2.77
Counteraction by MutT protein of transcriptional errors caused by oxidative damage. Science (1997) 2.67
Cloning and expression of cDNA for a human enzyme that hydrolyzes 8-oxo-dGTP, a mutagenic substrate for DNA synthesis. J Biol Chem (1993) 2.52
A prolactin-releasing peptide in the brain. Nature (1998) 2.43
Replication of plasmid pSC101 in Escherichia coli K12: requirement for dnaA function. Mol Gen Genet (1977) 2.43
Mutations of temperature sensitivity in R plasmid pSC101. J Bacteriol (1977) 2.38
Roles of V antigen in promoting virulence and immunity in yersiniae. J Immunol (1984) 2.32
Functional cooperation of MutT, MutM and MutY proteins in preventing mutations caused by spontaneous oxidation of guanine nucleotide in Escherichia coli. Mutat Res (1995) 2.28
Spontaneous pneumomediastinum in 33 patients: yield of chest computed tomography for the diagnosis of the mild type. Respiration (2000) 2.18
Structure and expression of the dnaQ mutator and the RNase H genes of Escherichia coli: overlap of the promoter regions. Proc Natl Acad Sci U S A (1983) 2.16
Purification and characterization of normal and mutant forms of T4 endonuclease V. J Biol Chem (1982) 2.14
THE SYNTHESIS OF MESSENGER RNA WITHOUT PROTEIN SYNTHESIS IN NORMAL AND PHAGE-INFECTED THYMINELESS STRAINS OF ESCHERICHIA COLI. Proc Natl Acad Sci U S A (1963) 2.12
A new gene (alkB) of Escherichia coli that controls sensitivity to methyl methane sulfonate. J Bacteriol (1983) 2.06
Hydrolytic elimination of a mutagenic nucleotide, 8-oxodGTP, by human 18-kilodalton protein: sanitization of nucleotide pool. Proc Natl Acad Sci U S A (1992) 2.04
Inhibition of DNA gyrase by optically active ofloxacin. Antimicrob Agents Chemother (1987) 2.03
Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. Am J Cardiol (2001) 2.03
Escherichia coli gene that controls sensitivity to alkylating agents. J Bacteriol (1978) 1.96
Purification and structure of the intact Ada regulatory protein of Escherichia coli K12, O6-methylguanine-DNA methyltransferase. J Biol Chem (1985) 1.95
Inhibition by quinolones of DNA gyrase from Staphylococcus aureus. Antimicrob Agents Chemother (1991) 1.93
A new conditional lethal mutator (dnaQ49) in Escherichia coli K12. Mol Gen Genet (1978) 1.93
Clinical and histopathological profile of sarcoidosis of the heart and acute idiopathic myocarditis. Concepts through a study employing endomyocardial biopsy. I. Sarcoidosis. Jpn Circ J (1980) 1.87
Antimicrobial activity of DV-7751a, a new fluoroquinolone. Antimicrob Agents Chemother (1993) 1.86
Antimycoplasmal activity of ofloxacin (DL-8280). Antimicrob Agents Chemother (1983) 1.86
Isolation of temperature-sensitive mutants of R plasmid by in vitro mutagenesis with hydroxylamine. J Bacteriol (1976) 1.86
Regulatory mechanisms for induction of synthesis of repair enzymes in response to alkylating agents: ada protein acts as a transcriptional regulator. Proc Natl Acad Sci U S A (1986) 1.84
Molecular cloning of an activated human oncogene, homologous to v-raf, from primary stomach cancer. Proc Natl Acad Sci U S A (1985) 1.83
Molecular cloning of a human gene that regulates chromosome condensation and is essential for cell proliferation. Mol Cell Biol (1986) 1.80
Functional comparison of D-serine and glycine in rodents: the effect on cloned NMDA receptors and the extracellular concentration. J Neurochem (1995) 1.79
Identification of the uvrD gene product of Escherichia coli as DNA helicase II and its induction by DNA-damaging agents. J Biol Chem (1984) 1.77
Decreased tensile strength of an epidural catheter during its removal by grasping with a hemostat. Anesth Analg (2001) 1.72
Physical association of pyrimidine dimer DNA glycosylase and apurinic/apyrimidinic DNA endonuclease essential for repair of ultraviolet-damaged DNA. Proc Natl Acad Sci U S A (1981) 1.71
Restoration of ultraviolet-induced unscheduled DNA synthesis of xeroderma pigmentosum cells by the concomitant treatment with bacteriophage T4 endonuclease V and HVJ (Sendai virus). Proc Natl Acad Sci U S A (1975) 1.71
Transforming gene from human stomach cancers and a noncancerous portion of stomach mucosa. Proc Natl Acad Sci U S A (1986) 1.71
A specific role of MutT protein: to prevent dG.dA mispairing in DNA replication. Proc Natl Acad Sci U S A (1989) 1.65
Isoforms of caveolin-1 and caveolar structure. J Cell Sci (2000) 1.65
Clustered adenine/thymine stretches are essential for function of a fission yeast replication origin. Mol Cell Biol (1999) 1.65
Studies on the pathogenicity of Yersinia enterocolitica. III. Comparative studies between Y. enterocolitica and Y. pseudotuberculosis. Microbiol Immunol (1977) 1.64
A dominant (mutD5) and a recessive (dnaQ49) mutator of Escherichia coli. J Mol Biol (1983) 1.64
The uvrD gene of E. coli encodes a DNA-dependent ATPase. Nature (1982) 1.64
Correlation between epithelial cell infectivity in vitro and O-antigen groups of Yersinia enterocolitica. Microbiol Immunol (1977) 1.64
Association of high-altitude pulmonary edema with the major histocompatibility complex. Circulation (1998) 1.61
Mechanism of repair of DNA in bacteriophage. II. Inability of ultraviolet-sensitive strains of bacteriophage in inducing an enzyme activity to excise pyrimidine dimers. J Mol Biol (1970) 1.61
Phosphorylation of 25-kDa synaptosome-associated protein. Possible involvement in protein kinase C-mediated regulation of neurotransmitter release. J Biol Chem (1996) 1.59
Structure and expression of the alkA gene of Escherichia coli involved in adaptive response to alkylating agents. J Biol Chem (1984) 1.59
Establishment of cultured cell lines derived from a human gastric carcinoma. Jpn J Exp Med (1978) 1.57
Identification of the dnaQ gene product and location of the structural gene for RNase H of Escherichia coli by cloning of the genes. Proc Natl Acad Sci U S A (1981) 1.53
Intracellular localization of 8-oxo-dGTPase in human cells, with special reference to the role of the enzyme in mitochondria. J Biol Chem (1995) 1.52
Coronary thrombosis in pathogenesis of acute myocardial infarction. Histopathological study of coronary arteries in 108 necropsied cases using serial section. Br Heart J (1978) 1.52
Spontaneous tumorigenesis in mice defective in the MTH1 gene encoding 8-oxo-dGTPase. Proc Natl Acad Sci U S A (2001) 1.48
Erythropoietin receptor-mediated inhibition of exocytotic glutamate release confers neuroprotection during chemical ischemia. J Biol Chem (2001) 1.44
Acetyl-CoA carboxylase from Escherichia coli: gene organization and nucleotide sequence of the biotin carboxylase subunit. Proc Natl Acad Sci U S A (1991) 1.44
MicroRNA-494 suppresses cell proliferation and induces senescence in A549 lung cancer cells. Cell Prolif (2011) 1.44
Eosinophil active cytokines and surface analysis of eosinophils in Churg-Strauss syndrome. Allergy Asthma Proc (1999) 1.43
Cloning and characterization of the alkA gene of Escherichia coli that encodes 3-methyladenine DNA glycosylase II. J Biol Chem (1984) 1.43
Three-dimensional structure of a DNA repair enzyme, 3-methyladenine DNA glycosylase II, from Escherichia coli. Cell (1996) 1.43
Nucleases specific for ultraviolet light-irradiated DNA and their possible role in dark repair. Cold Spring Harb Symp Quant Biol (1968) 1.42
Infant schistosomiasis in Ghana: a survey in an irrigation community. Trop Med Int Health (2004) 1.41
Catheter biopsy of the heart. Radiol Clin North Am (1971) 1.41
Inhibitory effects of quinolones on DNA gyrase of Escherichia coli and topoisomerase II of fetal calf thymus. Antimicrob Agents Chemother (1989) 1.39
Mechanism of repair of DNA in bacteriophage. I. Excision of pyrimidine dimers from ultraviolet-irradiated DNA by an extract of T4-infected cells. J Mol Biol (1970) 1.39
Shape memory in hydrogels. Nature (1995) 1.38
Expression and cloning of complementary DNA for a human enzyme that repairs O6-methylguanine in DNA. J Mol Biol (1990) 1.38
Molecular cloning and nucleotide sequence of the mutT mutator of Escherichia coli that causes A:T to C:G transversion. Mol Gen Genet (1987) 1.38
Urokinase-type plasminogen activator and its receptor in bladder cancer. J Natl Cancer Inst (1997) 1.37
Stimulation of the UvrABC enzyme-catalyzed repair reactions by the UvrD protein (DNA helicase II). Nucleic Acids Res (1985) 1.36
RNase H-defective mutants of Escherichia coli: a possible discriminatory role of RNase H in initiation of DNA replication. Mol Gen Genet (1984) 1.36
Structures and functions of DNA glycosylases. Mutat Res (1990) 1.34
Structure and expression of the alkB gene of Escherichia coli related to the repair of alkylated DNA. J Biol Chem (1986) 1.33
In-vitro and in-vivo activity of DR-3355, an optically active isomer of ofloxacin. J Antimicrob Chemother (1990) 1.32
A human enzyme that liberates uracil from DNA. Biochem Biophys Res Commun (1976) 1.32
Release of N2,3-ethenoguanine from chloroacetaldehyde-treated DNA by Escherichia coli 3-methyladenine DNA glycosylase II. Proc Natl Acad Sci U S A (1992) 1.30
Metabolic fate of oxidized guanine ribonucleotides in mammalian cells. Biochemistry (1999) 1.30
Prevention of graft coronary arteriosclerosis by antisense cdk2 kinase oligonucleotide. Nat Med (1997) 1.28
Conditional lethality of Escherichia coli strains carrying dnaE and dnaQ mutations. Mol Gen Genet (1981) 1.28
Proliferative activation of quiescent Rat-1A cells by delta FosB. Mol Cell Biol (1993) 1.27
Initial step of excision repair in Escherichia coli: replacement of defective function of uvr mutants by T4 endonuclease V. J Mol Biol (1972) 1.26
The high-affinity binding of Clostridium botulinum type B neurotoxin to synaptotagmin II associated with gangliosides GT1b/GD1a. FEBS Lett (1996) 1.25
Transfection analysis of functional roles of complexin I and II in the exocytosis of two different types of secretory vesicles. Biochem Biophys Res Commun (1999) 1.23
Improvement of eosinophilic heart disease after steroid therapy: successful demonstration by endomyocardial biopsied specimens. Heart Vessels (1999) 1.23
Structure and function of dnaQ and mutD mutators of Escherichia coli. Mol Gen Genet (1986) 1.22
Effect of L18-MDP(Ala), a synthetic derivative of muramyl dipeptide, on nonspecific resistance of mice to microbial infections. Infect Immun (1982) 1.22
Molecular cloning and characterization of the alkB gene of Escherichia coli. Mol Gen Genet (1985) 1.22